This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hyponatremia or Hypernatremia
and you are
between 18 and 110
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

Background: Hypo- and hypernatremia are common in hospitalized patients. The differential diagnosis of dysnatremia is challenging. Osmotically inadequate secretion of antidiuretic hormone (ADH) is the predominant mechanism in most dysnatremic disorders. ADH measurement is cumbersome. It is derived from a larger precursor peptide along with copeptin, which is a more stable peptide directly mirroring the production of ADH. Objective: To evaluate the additional value of copeptin to improve a currently used algorithm in the differential diagnosis of (A) severe hypoosmolar hypo- and (B) severe hypernatremia. Design: Prospective observational study.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01456533. The sponsor of the trial is University Hospital, Basel, Switzerland and it is looking for 300 volunteers for the current phase.
Official trial title:
Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized Patients